Saphena Medical
Young, energetic company with deep knowledge in the cardiovascular space.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | $2.1m | Series D | |
| Total Funding | 000k | ||
Related Content
Saphena Medical specializes in developing and manufacturing the Venapax Endoscopic Vessel Harvesting (EVH) system, which is designed to improve the quality of veins harvested for cardiovascular procedures. The company primarily serves hospitals and cardiovascular institutes, providing them with advanced medical devices that enhance surgical outcomes. Operating in the medical device market, Saphena Medical's business model revolves around the sale and distribution of its proprietary Venapax system. Revenue is generated through direct sales to healthcare institutions and through contracts with purchasing programs like Premier SURPASS. The Venapax system is praised for its ability to minimize vein distortion and reduce leg wound complications, making it a preferred choice among seasoned harvesters and medical professionals.
Keywords: EVH system, vein quality, cardiovascular procedures, medical devices, hospitals, healthcare, surgical outcomes, Premier SURPASS, vein harvesting, USA manufacturing.